RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • Receptor for Advanced Glycation End Product, Organ Crosstalk, and Pathomechanism Targets for Comprehensive Molecular Therapeutics in Diabetic Ischemic Stroke.

Receptor for Advanced Glycation End Product, Organ Crosstalk, and Pathomechanism Targets for Comprehensive Molecular Therapeutics in Diabetic Ischemic Stroke.

Add to Collection
2022 Nov 18 Others NL Rao, GB Kotian, JK Shetty, BP Shelley, MK Dmello… - Biomolecules, 2022 - mdpi.com

Full Author : ['Rao, Nivedita L', 'Kotian, Greeshma B', 'Shetty, Jeevan K', 'Shelley, Bhaskara P', 'Dmello, Mackwin Kenwood', 'Lobo, Eric C', 'Shankar, Suchetha Padar', 'Almeida, Shellette D', 'Shah, Saiqa R']
Journal Title : Biomolecules
Chapter : Section3
Journal Year : 2022

Diabetes mellitus, a well-established risk factor for stroke, is related to higher mortality and poorer outcomes following the stroke event. Advanced glycation end products(AGEs), their receptors RAGEs, other ligands, and several other processes contribut..... Read More

Keywords : ["advanced glycation end product organ crosstalk", "diabetic ischemic stroke", "comprehensive molecular therapeutic", "pathomechanism target", "receptor"]
PubMed Link : https://www.mdpi.com/2218-273X/12/11/1712